EDGAR Filing Documents for 0001193125-15-338577

Form 8-K - Current report:

SEC Accession No. 0001193125-15-338577

Filing Date

2015-10-06

Accepted

2015-10-06 17:17:34

Documents

Period of Report

2015-10-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d39856d8k.htm	8-K	20872
2	EX-1.1	d39856dex11.htm	EX-1.1	193474
3	EX-5.1	d39856dex51.htm	EX-5.1	6501
4	EX-99.1	d39856dex991.htm	EX-99.1	7379
5	EX-99.2	d39856dex992.htm	EX-99.2	7636
6	GRAPHIC	g39856ex5_1logo.jpg	GRAPHIC	7382
7	GRAPHIC	g39856ex99_1logo.jpg	GRAPHIC	11300
8	GRAPHIC	g39856ex99_2logo.jpg	GRAPHIC	11300
	Complete submission text file	0001193125-15-338577.txt		279109

Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142

Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000

Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)